Opposing effects of engagement of integrins and stimulation of cytokine receptors on cell cycle progression of normal human hematopoietic progenitors

Blood

Volumn 95, Issue 3, 2000, Pages 846-854

  Jiang, Yuehua ^c   Prosper, Felipe ^c   Verfaillie, Catherine M ^a,b  

^a The Leukemia & Lymphoma Society   (United States)

^b UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYTOKINE RECEPTOR; INTERLEUKIN 3; PROTEIN P27; REGULATOR PROTEIN; STEM CELL FACTOR;

ARTICLE; CELL CYCLE; CELL CYCLE S PHASE; CYTOKINE RELEASE; ENZYME ACTIVITY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEADY STATE;

EID: 0034142196     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.3.846.003k31_846_854     Document Type: Article

References (68)

1. Coulombel L, Auffray I, Gaugler MH, Rosemblatt M. Expression and function of integrins on hematopoietic progenitor cells. Acta Haematol. 1997; 97:13-21.
2. Simmons PJ, Levesque JP, Zannettino AC. Adhesion molecules in haemopoiesis. Baillieres Clin Haematol. 1997;10:485-505.
3. Verfaillie CM, McCarthy JB, McGlave PB. Differentiation of primitive human multipotent hematopoietic progenitors into single lineage clonogenic progenitors is accompanied by alterations in their interaction with FN. J Exp Med. 1991;174:693-703.
4. Verfaillie CM. Direct contact between progenitors and stroma is not required for human in vitro hematopoiesis. Blood. 1992;79:2821-2826.
5. Hurley RW, McCarthy JB, Verfaillie CM. Direct adhesion to bone marrow stroma via FN receptors inhibits hematopoietic progenitor proliferation. J Clin Invest. 1995;96:511-519.
6. Verfaillie CM, Catanzarro P. Development of a novel single LTC-IC proliferation assay that can determine the fate of LTC-IC over time. Leukemia. 1996;10:498-504.
7. Hurley R, McCarthy JB, Verfaillie CM. Monoclonal antibody crosslinking of the alpha 4 or beta 1 integrin inhibits committed clonogenic hematopoietic progenitor proliferation. Exp Hematol. 1997;25: 321-328.
8. Aota S, Yamada KM. Integrin functions and signal transduction. Adv Exp Med Biol. 1997;400B:669-682.
9. Shattil SJ, Kashiwagi H, Pampori N. Integrin signaling: the platelet paradigm. Blood. 1998;91: 2645-2657.
10. Yamada KM. Integrin signaling. Matrix Biol. 1997; 16:137-141.
11. Malik RK. Regulation of apoptosis by integrin receptors. J Pediatr Hematol Oncol. 1997;19:541-545.
12. Frisch SM, Ruoslahti E. Integrins and anoikis. Curr Opin Cell Biol. 1997;9:701-706.
13. Giancotti FG. Integrin signaling: specificity and control of cell survival and cell cycle progression. Curr Opin Cell Biol. 1997;9:691-700.
14. Howe A, Aplin AE, Alahari SK, Juliano RL. Integrin signaling and cell growth control. Curr Opin Cell Biol. 1998;10:220-231.
15. Juliano R. Cooperation between soluble factors and integrin-mediated cell anchorage in the control of cell growth and differentiation. Bioessays. 1996;18:911-917.
16. Guan JL. Focal adhesion kinase in integrin signaling. Matrix Biol. 1997;16:195-200.
17. Avraham S, Avraham H. Characterization of the novel focal adhesion kinase RAFTK in hematopoietic cells. Leuk Lymphoma. 1997;27:247-256.
18. Hannigan GE, Dedhar S. Protein kinase mediators of integrin signal transduction. J Mol Med. 1997;75:35-44.
19. Malik RK, Parsons JT. Integrin-mediated signaling in normal and malignant cells: a role of protein tyrosine kinases. Biochem Biophys Acta. 1996; 1287:73-76.
20. Petruzzelli L, Takami M, Herrera R. Adhesion through the interaction of lymphocyte function-associated antigen-1 with intracellular adhesion molecule-1 induces tyrosine phosphorylation of p130cas and its association with c-Crkll. J Biol Chem. 1996;271:7796-7801.
21. Petruzzelli L, Takami M, Herrera R, et al. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature. 1994;372:786-791.
22. Manie SN, Beck AR, Astier A, et al. Involvement of p130(Cas) and p105(HEF1), a novel Cas-like docking protein, in a cytoskeleton-dependent signaling pathway initiated by ligation of integrin or antigen receptor on human B cells. J Biol Chem. 1997;272:4230-4236.
23. Shimizu Y, Hunt SW III. Regulating integrin-mediated adhesion: one more function for PI 3-kinase? Immunol Today. 1996;17:565-573.
24. Yurochko AD, Liu DY, Eierman D, Haskill S. Integrins as a primary signal transduction molecule regulating monocyte immediate-early gene induction. Proc Natl Acad Sci U S A. 1992;89:9034-9038.
25. Zhu X, Ohtsubo M, Bohmer RM, Roberts JM, Assoian RK. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein. J Cell Biol. 1996; 133:391-403.
26. Fang F, Orend G, Watanabe N, Hunter T, Ruoslahti E. Dependence of cyclin E-CDK2 kinase activity on cell anchorage. Science. 1996;271: 499-502.
27. Shulze A, Zerfass-Thome K, Berges J, Middendorp S, Jansen-Durr P, Henglein B. Anchorage-dependent transcription of the cyclin A gene. Mol Cell Biol. 1996;16:4632-4638.
28. Levesque JP, Haylock DN, Simmons PJ. Cytokine regulation of proliferation and cell adhesion are correlated events in human CD34+ hematopoietic progenitors. Blood. 1996;88:1168-1176.
29. Levesque JP, Leavesley DI, Niutta S, Vadas M, Simmons PJ. Cytokines increase human hematopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins. J Exp Med. 1995;181:1805-1815.
30. Kovach NL, Lin N, Yednock T, Harlan JM, Broudy VC. Stem cell factor modulates avidity of alpha 4 beta 1 and alpha 5 beta 1 integrins expressed on hematopoietic cell lines. Blood. 1995;85:159-167.
31. Schofield KP, Rushton G, Humphries MJ, Dexter TM, Gallagher JT. Influence of interleukin-3 and other growth factors on alpha4beta1 integrin-mediated adhesion and migration of human hematopoietic progenitor cells. Blood. 1997;90:1858-1866.
32. Strobel ES, Mobest D, von Kleist S, et al. Adhesion and migration are differentially regulated in hematopoietic progenitor cells by cytokines and extracellular matrix. Blood. 1997;90:3524-3532.
33. Simmons PJ, Haylock DN. Use of hematopoietic growth factors for in vitro expansion of precursor cell populations. Curr Opin Hematol. 1995;2:189-195.
34. Schofield KP, Humphries MJ, de Wynter E, Testa N, Gallagher JT. The effect of alpha4 beta1-integrin binding sequences of FN on growth of cells from human hematopoietic progenitors. Blood. 1998;91:3230-3238.
35. Lundell BI, McCarthy JB, Kovach NL, Verfaillie CM. Activation-dependent alpha5beta1 integrin-mediated adhesion to fibronectin decreases proliferation of chronic myelogenous leukemia progenitors and K562 cells. Blood. 1996;87: 2450-2458.
36. Prosper F, McCarthy JD, Stroncek D, Verfaillie CM. Mobilization and homing of peripheral blood progenitors is related to reversible downregulation of α4 βετα1 integrin expression and function. J Clin Invest. 1998;101:2456-2467.
37. Gupta P, McCarthy JB, Verfaillie CM. Stromal fibroblast heparan sulfate is required for cytokine-mediated ex vivo maintenance of human long-term culture-initiating cells. Blood. 1996;87:3229-3236.
38. Vindelov LL, Christensen IJ. A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysis. Cytometry. 1990;11:753-770.
39. Zhao RC, McIvor RS, Grffin JD, Verfaillie CM. Gene therapy for chronic myelogenous leukemia (CML): a retroviral vector that renders hematopoietic progenitors methotrexate-resistant and CML progenitors functionally normal and nontumorigenic in vivo. Blood. 1997;90:4687-4698.
40. 0. Blood. 1997;90: 658-668.
41. Lemoli RM, Tafuri A, Fortuna A, et al. Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor. Blood. 1997;89:1189-1196.
42. Williams CD, Linch DC, Watts MJ, Thomas NS. Characterization of cell cycle status and E2F complexes in mobilized CD34+ cells before and after cytokine stimulation. Blood. 1997;90:194-203.
43. Cashman J, Eaves AC, Eaves CJ. Regulated proliferation of primitive hematopoietic progenitor cells in long-term human marrow cultures. Blood. 1985;66:1002-1005.
44. Eaves CJ, Cashman JD, Kay RJ, et al. Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer. Blood. 1991;78:110-117.
45. Gupta P, Oegema TR, Verfaillie CM. Differences in the LTC-IC maintaining capacity of stromal cells correlates with patterns of sulfation of their heparan sulfate glycosaminoglycans. In Press. Blood.
46. Bruno E, Luikart SD, Long MW, Hoffman R. Marrow-derived heparan sulfate proteoglycan mediates the adhesion of hematopoietic progenitor cells to cytokines. Exp Hematol. 1995;23:1212-1217.
47. Schofield R. The stem cell system. Biomed Pharmacother. 1983;37:375-380.
48. Zannettino AC, Berndt MC, Butcher C, Butcher EC, Vadas MA, Simmons PJ. Primitive human hematopoietic progenitors adhere to P-selectin (CD62P). Blood. 1995;85:3466-3477.
49. Watt SM, Buhring HJ, Rappold I, et al. CD164, a novel sialomucin on CD34(+) and erythroid subsets, is located on human chromosome 6q21. Blood. 1998;92:849-866.
50. Bazil V, Brandt J, Chen S, et al. A monoclonal antibody recognizing CD43 (leukosialin) initiates apoptosis of human hemalopoietic progenitor cells but not stem cells. Blood. 1996;87:1272-1281.
51. Moritz T, Dutt P, Xiao X, et al. Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors: evidence of direct viral binding to chymotryptic carboxy-terminal fragments. Blood. 1996;88:855-862.
52. Gong J, Ko TC, Brattain MG. Disruption of FN binding to the alpha 5 beta 1 integrin stimulates the expression of cyclin-dependent kinases and DNA synthesis through activation of extracellular signal-regulated kinase. J Biol Chem. 1998;273: 1662-1669.
53. Koyama H, Raines EW, Bornfeldt KE, Roberts JM, Ross R. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell. 1996;87:1069-1078.
54. Chen CS, Mrksich M, Huang S, Whitesides GM, Ingber DE. Geometric control of cell life and death. Science. 1997;276:1425-1428.
55. Kato A, Takahashi H, Takahashi Y, Matsushime H. Inactivation of the cyclin D-dependent kinase in the rat fibroblast cell line, 3Y1, induced by contact inhibition. J Biol Chem. 1997;272:8065-8070.
56. Nakayama K, Ishida N, Shirane M, et al. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell. 1996;85:707-720.
57. Johnson D, Frame MC, Wake JA. Expression of the v-Src oncoprotein in fibroblasts disrupts normal regulation of the CDK inhibitor p27 and inhibits quiescence. Oncogene. 1998;16:2017-2028.
58. Flinch IL, Ana S, Mantra N, Bah JJ, Moroccan E. Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes. J Mol Cell Cardiol. 1998;30:563-578.
59. Vlach J, Hennecke S, Amati B. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO J. 1997;16:5334-5344.
60. Bagley CJ, Woodcock JM, Stomski FC, Lopez AF. The structural and functional basis of cytokine receptor activation: lessons from the common beta subunit of the granulocyte-rnacrophage colony-stimulating factor, interteukin-3 (IL-3), and IL-5 receptors. Blood. 1997;89:1471-1482.
61. Lyman SD, Jacobsen SE. C-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood. 1998;91:1101-1134.
62. Takahira H, Gotoh A, Ritchie A, Broxmeyer HE. Steel factor enhances integrin-mediated tyrosine phosphorylation of focal adhesion kinase (pp125FAK) and paxillin. Blood. 1997;89:1574-1584.
63. Sattler M, Sakjia R, Shrikhande G, et al. Steel factor induces tyrosine phosphorylation of CRKL and binding of CRKL to a complex containing c-kit, phosphatidylinositol 3-kinase, and p120(CBL). J Biol Chem. 1997;272:10,248-10,253.
64. Hara T, Miyajima A. Function and signal transduction mediated by the interleukin 3 receptor system in hematopoiesis. Stem Cells. 1996;14:605-618.
65. Anderson SM, Burton EA, Koch BL. Phosphorylation of CbI following stimulation with interleukin-3 and its association with Grb2, Fyn, and phosphatidylinositol 3-kinase. J Biol Chem. 1997;272:739-745.
66. Barber DL, Mason JM, Fukazawa T, et al. Erythropoietin and interleukin-3 activate tyrosine phosphorylation of CBL and association with CRK adaptor proteins. Blood. 1997;89:3166-3174.
67. Salgia R, Li JL, Lo SH, et al. Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by P210BCR/ABL. J Biol Chem. 1995; 270:5039-5047.
68. O'Farrell AM, Ichihara M, Mui AL, Miyajima A. Signaling pathways activated in a unique mast cell line where interleukin-3 supports survival and stem cell factor is required for a proliferate response. Blood. 1996;87:3655-3668.